CONSOLIDATED STATEMENT OF CASH FLOWS - USD ($)
$ in Millions |
12 Months Ended |
Oct. 31, 2017 |
Oct. 31, 2016 |
Oct. 31, 2015 |
| Cash flows from operating activities: |
|
|
|
| Net income |
$ 684
|
$ 462
|
$ 401
|
| Adjustments to reconcile net income to net cash provided by operating activities: |
|
|
|
| Depreciation and amortization |
212
|
246
|
253
|
| Share-based compensation |
60
|
58
|
54
|
| Deferred taxes |
102
|
3
|
70
|
| Excess and obsolete inventory related charges |
24
|
20
|
30
|
| Asset impairment charges |
0
|
4
|
3
|
| Impairment of equity method investments and loans |
0
|
25
|
0
|
| Other |
7
|
15
|
16
|
| Changes in assets and liabilities: |
|
|
|
| Accounts receivable, net |
(81)
|
(33)
|
(24)
|
| Inventory |
(61)
|
(7)
|
(24)
|
| Accounts payable |
2
|
(15)
|
(26)
|
| Employee compensation and benefits |
38
|
15
|
8
|
| Interest rate swap payments |
0
|
(10)
|
0
|
| Other assets and liabilities |
(98)
|
10
|
(249)
|
| Net cash provided by operating activities |
889
|
793
|
512
|
| Cash flows from investing activities: |
|
|
|
| Investments in property, plant and equipment |
(176)
|
(139)
|
(98)
|
| Proceeds from the sale of property, plant and equipment |
0
|
0
|
12
|
| Proceeds from the sale of investment securities |
0
|
1
|
0
|
| Proceeds from divestitures |
2
|
0
|
3
|
| Payment to acquire cost method investment |
(1)
|
(80)
|
0
|
| Payment to acquire equity method investment |
0
|
0
|
(1)
|
| Payment in exchange for convertible note |
(1)
|
(1)
|
(2)
|
| Loan to equity method investment |
0
|
(3)
|
0
|
| Change in restricted cash, cash equivalents and investments, net |
(1)
|
245
|
(240)
|
| Acquisitions of businesses and intangible assets, net of cash acquired |
(128)
|
(261)
|
(74)
|
| Net cash used in investing activities |
(305)
|
(238)
|
(400)
|
| Cash flows from financing activities: |
|
|
|
| Issuance of common stock under employee stock plans |
66
|
62
|
58
|
| Payment of taxes related to net share settlement of equity awards |
(14)
|
(6)
|
(13)
|
| Treasury stock repurchases |
(194)
|
(434)
|
(267)
|
| Payment of dividends |
(170)
|
(150)
|
(133)
|
| Issuance of senior notes |
0
|
299
|
0
|
| Debt issuance costs |
0
|
(2)
|
0
|
| Proceeds from debts and credit facility |
400
|
255
|
0
|
| Repayments of debt and credit facility |
(290)
|
(292)
|
0
|
| Net transfer of cash and cash equivalents to Keysight |
0
|
0
|
(734)
|
| Net cash used in financing activities |
(202)
|
(268)
|
(1,089)
|
| Effect of exchange rate movements |
7
|
(1)
|
(48)
|
| Net increase (decrease) in cash and cash equivalents |
389
|
286
|
(1,025)
|
| Cash and cash equivalents at beginning of year |
2,289
|
2,003
|
|
| Cash and cash equivalents at end of year |
2,678
|
2,289
|
2,003
|
| Supplemental Cash Flow Information [Abstract] |
|
|
|
| Income tax payments, net |
63
|
67
|
129
|
| Interest payments |
$ 82
|
$ 73
|
71
|
| Continuing Operations |
|
|
|
| Cash flows from financing activities: |
|
|
|
| Cash and cash equivalents at beginning of year |
|
|
2,218
|
| Discontinued Operations |
|
|
|
| Cash flows from financing activities: |
|
|
|
| Cash and cash equivalents at beginning of year |
|
|
$ 810
|